BRENNER ERIN K. (Chief Product Dev. Officer) sold 16.7% of their position (8.69K shares) of PEAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/24/2023ACC: 0001062993-23-001327
Officer· Chief Product Dev. Officer
Since Dec 2021
-8.69K
Net shares
Net seller
$9.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.69K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−8.69K
Price / share
$1.13
Trade value
$9.82K
% of position
16.7%
1/20/2023
52K→43.31K
Total
Net shares
−8.69K
Net value
-$9.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 1/20/2023 | S · Sale | −8.69K | $1.13 | $9.82K | 16.7% | 52K | 43.31K |
| Total | −8.69K | -$9.82K | ||||||
Derivative Transactions0
No derivative transactions reported